Anduril cofounder’s startup Warhound raises $200 mn to develop ‘genetically enhanced’ military dogs
Warhound has secured $200 million in funding to develop what the company describes as 'genetically enhanced' military dogs. The startup plans to leverage biotechnology expertise from Colossal Biosciences alongside defense technology from Anduril Industries to establish a domestic supply of working dogs for U.S. defense purposes. This represents a notable funding round in the emerging intersection of biotech and defense innovation.
Key points
- $200M funding round for military dog biotech startup
- Combines Colossal Biosciences biotech with Anduril defense expertise
- Aims to develop domestic supply of enhanced working dogs for US defense
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. ThePrint Tech did the reporting; read the original for the full story.
Read the full story at ThePrint Tech
